Sigyn Therapeutics, Inc. (SIGY) SEC Filings https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/rss Sigyn Therapeutics, Inc. (SIGY) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/sigyntherapeutics/files/theme/images/logo-sm.png Sigyn Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[NT 10-K - Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-26-014344/0001493152-26-014344.pdf Tue, 31 Mar 26 17:21:34 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-26-014344/0001493152-26-014344.pdf <![CDATA[8-K - Current report]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-26-007574/0001493152-26-007574.pdf Fri, 20 Feb 26 14:44:46 -0500 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-26-007574/0001493152-26-007574.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001213900-26-004186/0001213900-26-004186.pdf Wed, 14 Jan 26 09:09:16 -0500 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001213900-26-004186/0001213900-26-004186.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-25-023387/0001493152-25-023387.pdf Fri, 14 Nov 25 16:05:00 -0500 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001493152-25-023387/0001493152-25-023387.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-026704/0001641172-25-026704.pdf Fri, 05 Sep 25 15:49:17 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-026704/0001641172-25-026704.pdf <![CDATA[8-K - Current report]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-024303/0001641172-25-024303.pdf Fri, 15 Aug 25 11:12:03 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-024303/0001641172-25-024303.pdf <![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-024221/0001641172-25-024221.pdf Fri, 15 Aug 25 06:06:31 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-024221/0001641172-25-024221.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-011815/0001641172-25-011815.pdf Tue, 20 May 25 17:31:35 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-011815/0001641172-25-011815.pdf <![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-010720/0001641172-25-010720.pdf Thu, 15 May 25 14:16:50 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-010720/0001641172-25-010720.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-004740/0001641172-25-004740.pdf Tue, 15 Apr 25 13:43:06 -0400 https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001641172-25-004740/0001641172-25-004740.pdf